The role of vitamin E in human nutrition was studied by investigation of patients with cystic fibrosis (CF) and associated pancreatic insufficiency. Vitamin E status was assessed by measurement of the plasma concentration of the principal circulating isomer, a-tocopherol. Results of such determinations in 52 CF patients with pancreatogenic steatorrhea revealed that all were deficient in the vitamin. The extent of decreased plasma tocopherol varied markedly but correlated with indices of intestinal malabsorption, such as the serum carotene concentration and percentage of dietary fat absorbed. Supplementation with 5-10 times the recommended daily allowance of vitamin E in a water-miscible form increased the plasma a-tocopherol concentrations to normal in all 19 CF patients so evaluated.
A B S T R A C T The role of vitamin E in human nutrition was studied by investigation of patients with cystic fibrosis (CF) and associated pancreatic insufficiency. Vitamin E status was assessed by measurement of the plasma concentration of the principal circulating isomer, a-tocopherol. Results of such determinations in 52 CF patients with pancreatogenic steatorrhea revealed that all were deficient in the vitamin. The extent of decreased plasma tocopherol varied markedly but correlated with indices of intestinal malabsorption, such as the serum carotene concentration and percentage of dietary fat absorbed. Supplementation with [5] [6] [7] [8] [9] [10] times the recommended daily allowance of vitamin E in a water-miscible form increased the plasma a-tocopherol concentrations to normal in all 19 CF patients so evaluated.
Studies on the effects of vitamin E deficiency focused on possible hematologic alterations. An improved technique was developed to measure erythrocyte hemolysis in vitro in the presence of hydrogen peroxide. While erythrocyte suspensions from control subjects demonstrated resistance to hemolysis during a 3-h incubation, all samples from tocopherol-deficient CF patients showed abnormal oxidant susceptibility, evidenced by greater than 5% hemoglobin release. The degree of peroxide-induced hemolysis was related to the plasma a-tocopherol concentration in an inverse, sigmoidal manner. The possibility of in vivo hemolysis was assessed by measuring the survival of 5'Cr-labeled erythrocytes in 19 vitamin-E deficient patients. A moderate but statistically significant decrease in the mean 51Cr erythrocyte half-life value was found in this group. Measurement of erythrocyte survival before and after supplementation of 6 patients with vitamin E demonstrated that the shortened erythrocyte lifespan could be corrected to normal with this treatment. Other hematologic indices in deficient subjects, however, were normal and did not change upon supplementation with vitamin E.
It is concluded that CF is invariably associated with vitamin E deficiency, provided that the patient in question has pancreatic achylia and is not taking supplementary doses of tocopherol. Concomitant hematologic effects consistent with mild hemolysis, but not anemia, occur and may be reversed with vitamin E therapy. Patients with CF should be given daily doses of a water-miscible form of vitamin E to correct the deficiency. INTRODUCTION A variety of vitamin E deficiency syndromes are readily produced in lower animals, but man (with the possible exception of the premature infant) has not been shown to develop symptoms in the face of diminished tocopherol. The various etiologies (1, 2) and in prematurely delivered newborns (3, 4) . To study chronic vitamin E deficiency in children and adults, it is therefore necessary to utilize patients with intestinal malabsorption. Despite the presence of abnormalities in some laboratory indices identified in earlier work (1, 3) , there are no convincing data that define the physiological derangements attributable to low tocopherol in these patients (5). Of several disorders accompanied by steatorrhea, cystic fibrosis (CF)' with pancreatic achylia represents one of the most common causes of the malabsorption syndrome in the United States (6) . Previous studies on the vitamin E status of CF patients, however, have been limited in scope and hampered by the small population of available subjects (1, 7) . This work has also yielded conflicting data in regard to both the concentration of circulating tocopherol in malabsorption states and the susceptibility oferythrocytes to peroxideinduced hemolysis (an index of erythrocyte vitamin E) (1, 8, 9) . Another limitation of previous studies is that they have not provided data on the ratio of a-tocopherol to circulating lipid, an expression which represents the most reliable index of vitamin E status routinely available in humans (10) .
The existence of the above discrepancies and the complex presentation of tocopherol deficiency syndromes in animals indicated to us that a comprehensive approach with a large population of patients was most desirable to study vitamin E deficiency in CF. Accordingly, a group of such patients was evaluated with the overall goal being to determine whether or not vitamin E deficiency in man, generally, and in CF patients, particularly, leads to significant disturbances such as those which have been identified in animals. Specifically, the degree of vitamin E deficiency, its relationship to the extent of fat malabsorption, and the possible effects of diminished tocopherol were examined in these patients.
METHODS
Subjects. A total of 61 CF patients, 25 females and 36 males, were available for evaluation. The ages of these patients ranged from 1 to 42 yr (mean = 17 yr). Their diagnoses were established firmly by the presence of at lea$t three of the four standard criteria for the disease: positive family history, pancreatic insufficiency, chronic obstructive pulmonary disease, and elevated sweat electrolytes. For purposes of this investigation, the patients were divided into three groups. The first group consisted of 52 subjects who had clinical or laboratory evidence of pancreatic insufficiency and who were not receiving supplementary tocopherol when the study began. The second group was comprised of seven patients with pancreatic insufficiency who, when first evaluated, were consuming 1-10 IU/kg per day of vita-'Abbreviations used in this paper: CF, cystic fibrosis; PBS, phosphate-buffered saline; RBC, erythrocytes. min E (either on a referring physician's instructions or on a self-prescribed basis). The third group consisted of two patients who were not ingesting supplementary vitamin E, but who had evidence of either partially or completely intact digestive function.
The control subjects were 32 young adults ranging from 18 to 40 yr of age. These were either normal volunteers or employees of the National Institutes of Health. None had any history or evidence of pulmonary or gastrointestinal disease.
Samples obtained for analysis. Informed consent was obtained from all patients and control subjects used in the procedures described herein. Blood samples, obtained in the fasting state by venipuncture, were heparinized, centrifuged within 2 h, and the plasma collected and frozen for 1-5 days before extraction of lipids. Erythrocytes utilized for measurement of a-tocopherol concentration were washed twice with phosphate-buffered saline (PBS) at pH 7.4. Tissues were available from four patients who expired during the course of these studies and came to autopsy within 12 h of death. Whenever possible, 1-5-g samples of liver, heart, psoas muscle, lung, and adipose tissue were obtained, removed of adhering fat, and frozen at -20°C until tocopherol determinations could be performed (generally within 1 wk).
Determination of a-tocopherol. Measurement of atocopherol, the most abundant and active isomer of vitamin E in man, was performed after thin-layer chromatography by the method of Bieri Erythrocyte and tissue a-tocopherol was measured after saponification under nitrogen in the presence of pyrogallol as described by Bieri (12) . The type of thin-layer plate and the first solvent were the same as for plasma analysis; the second solvent was hexane:ethanol (9:1). Trace amounts of 3H-a-tocopherol were added in the initial extraction step for each sample, recoveries determined, and final results correlated for losses during analysis as described previously (13) .
Erythrocyte hemolysis in vitro. This was measured after addition of hydrogen peroxide (H202) with a technique modified from that described by Horwitt et al. (14) . (15) . Labeling with radiochromium was carried out with 10-ml samples of venous blood mixed with acid-citrate dextrose; approximately 1 ,uCi of 5'Cr was added per kilogram of body weight. Blood samples of 5-ml volume were drawn 1 h after injection and every 2 or 3 days until a total of 12 specimens were available for determination of radioactivity. All tubes were counted at the same time to a statistical accuracy of +2%. Data obtained were corrected for chromium elution, which was found to be the same for vitamin E-deficient erythrocytes and control samples.
Absorptive function studies. These were carried out on 21 patients admitted to the National Institutes of Health Clinical Center for at least 1 wk who cooperated for balance studies. They were fed a diet of known composition providing approximately 100 g of fat per day. A carmine marker was given on the first hospital day and when this had been excreted, stool collection began and continued for 72 h. Pools of feces were then weighed and homogenized, and duplicate aliquots removed for extraction and measurement of fat as total fatty acids by the method of van de Kamer et al. (16) . The concentration of carotene in serum samples from 25 CF patients was deternined by extraction with petroleum ether and measurement of absorbance at 450 nm.
Lipid determinations. The triglyceride concentration of plasma samples obtained in the fasting state was measured by the procedure of Kessler and Lederer (17) . Total plasma lipids were measured by the turbidimetric method of de la Huerga et al. (18) after extraction with ethyl ether/ethanol (1:3). The fatty acid composition of erythrocytes was determined with a total lipid extract prepared with isopropanol-chloroform according to the procedure described by Bieri and Poukka (19) .
RE SULTS
Vitamin E status ofCF patients before supplementation. As indicated in Table I , the 52 CF patients with evidence of steatorrhea exhibited a significant decrease in the mean level of a-tocopherol, with an average value equal to only 15% of that found in 32 control subjects. Plasma triglyceride concentrations, measured in 20 young adults with CF, were not found to be statistically different from values obtained in agematched controls. Thus, the ratio of a-tocopherol to triglycerides in plasma was markedly lower in CF patients (0.89 ,ug/mg), compared to normal subjects (6.44 Ag/mg). A similar difference was noted in comparing a-tocopherol/total lipid ratios in a limited number of subjects. Five (Table III) . Comparing erythrocytes with plasma in terms of the magnitude of diminished tocopherol revealed that CF patients manifest a less pronounced decrease in the cellular fraction of blood. Thus, erythrocyte vitamin E was 18% of the control mean, whereas the plasma level fell to 5% of the control value in these patients. This difference resulted in a significantly elevated erythrocyte:plasma tocopherol ratio in unsupplemented CF patients compared to controls (Table III) . Evaluation oferythrocyte fatty acid composition indicated that the major abnormalities in CF erythrocytes are a relatively high content of palmitoleate and oleate and a lower concentration of linoleate. In addition, erythrocytes from the vitamin E-deficient patients showed a higher (P < 0.001) proportion of homo-ylinolenic acid (20:3w6) and minor differences in other fatty acids, which were not statistically significant. Because of the reduction in linoleic acid and slightly lower amounts of other polyunsaturated fatty acids, the total polyunsaturated fatty acid content of CF erythrocytes was lower than the controls. There was no statistical difference, however, in the peroxidizable indices of the two groups (Table III Once the optimal conditions were determined, the routine test procedure was utilized to evaluate blood samples from all CF patients visiting the National Institutes of Health Clinical Center duiring a 5-mo interval. This included 31 subjects with pancreatic insufficiency who were not receiving supplements of vitamin E; none of these patients were taking salicylates or were iron deficient, both of which can influence hemolysis test results. The degree of RBC hemolysis in these subjects ranged from 5 to 98% with a mean ±SE of 78±4.5%. This value is significantly higher (P < 0.001) than that of 32 controls (mean = 0.53 +0.12; range = 0-2%). In contrast, the one CF patient with normal pancreatic function and all vitamin Esupplemented patients showed less than 2% hemoglobin release during 3-h incubations.
The relationship between the percentage of RBC hemolysis in H202 and the concentration of a-tocopherol in plasma is shown in Fig. 3 . It is evident that significant hemolysis (>2%) occurred in all samples with less than 400 ,ug a-tocopherol per dl plasma. There is a relatively abrtupt change from atocopherol levels which permit a low degree of hemolysis (300-400 ,tg/dl) to those at which hemolysis is extensive (<200,ug/dl). Thus, the relationship between the degree of hemolysis and the plasma a-tocopherol concentration is sigmoidal in natuire.
Hemolysis in vivo measured after 51Cr-labeling oJ erythrocytes. As shown in Table IV , 19 vitamin Edeficient CF patients were evaluated in terms of 5'Cr-RBC sturvival and compared to 28 control subjects who showed values ranging from 25 to 35 days. The vitamin E-deficient group was found to have a significantly decreased mean 5'Cr-RBC ti valtue of 22.4 days and a range of 15.5-29 days. Three CF patients were particuilarly low with values of 15.5, 16 .0, aind 18.0 days. Fouir suibjects were in the normal range, however, and 52% of the valuies in the CF grouip were between 20 and 23 days, and thuis only mildly shortened. No correlation couild be fouind in comparing the extent of shortened 51Cr-RBC sturvival with the degree of vitamin E deficiency.
In six patients, it was possible to assess 51Cr-RBC PLASMA a-TOCOPHEROL ( g/l100 ml) 800 FIGURE 3 The relationship between the degree of peroxideinduced hemolysis and the plasma a-tocopherol level in CF patients. Thle sigmoid curve was drawn to approximate the apparent trend of the data.
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P. Farrell, J. Bieri, J. Fratantoni, R. Wood, and P. di Sant'Agnese 84%, the group showed a 51Cr-ti value of 19.0±1.3 days (mean±SE). This was significantly increased to 27.5±0.9 days after supplementation, when all of the subjects showed lower hemolysis in vitro as well, and a corresponding rise in plasma a-tocopherol concentration.
Other hematologic indices before and after supplementation with vitamin E. A group of 14 CF patients with low plasma tocopherol concentrations (mean = 84+12 ,ug/dl) who were in a relatively stable condition were evaluated for 2 yr in regard to hematologic status. During the 1st yr, while in the vitamin Edeficient state, hemoglobin and hematocrit values, RBC counts, and reticulocyte counts were measured on two or three occasions. None of the patients was found to have either anemia or presistent reticulocytosis (mean hemoglobin = 14.3,g/dl). Each member of this group then consumed 100-200 IU/day of vitamin E for 1 yr, during which time all patients showed a rise in plasma a-tocopherol to normal levels (mean ±SE = 780+68; P < 0.001, as compared to the pretreatment level). There was no change, however, in any of the hematologic indices.
DISCUSSION
Studies of human vitamin E deficiency are limited to two populations in developed countries, premature infants and patients with intestinal malabsorption. A number of malabsorptive states have attracted interest relative to vitamin E. These include CF, hepatobiliary disturbances such as biliary atresia, celiac disease, intestinal lymphangectasia, and abetalipoproteinemia (1, 23) . Relatively few patients with each of these disorders, however, have been characterized in terms of vitamin E status, and those who have been studied exhibit an unexplained wide range of blood tocopherol levels. Assessment of vitamin E status in such patients has generally been carried out with methods that measure total tocopherols (a-, /8-, and y-isomers) in plasma or serum (1, (7) (8) (9) . Although satisfactory for screening purposes, they overestimate the true circulating vitamin E level by 10-20%; and in patients taking drugs, the error may be greater. In addition, none of the previous investigations have delineated tocopherol:lipid ratios (10), and few have documented the extent of fat malabsorption in individual subjects.
Because of their chronic steatorrhea, patients with CF are particularly suitable for evaluation ofthe degree and effects of vitamin E deficiency in man. Focusing on this malabsorption syndrome, the present study demonstrates that CF patients with pancreatic achylia are uniformly low in plasma a-tocopherol, unless they are ingesting large dietary supplements of the vitamin. The observation that these patients are truly deficient in vitamin E was confirmed by measuring (27) .
A group of CF patients consuming supplements of vitamin E when this investigation was initiated, and the willingness of several additional subjects to cooperate for a trial of vitamin E administration, permitted us to assess the adequacy of dietary supplementation. It was found that ingestion of an appropriate preparation of a-tocopherol in doses above the recommended daily allowance overcomes the deficiency state in nearly all cases. Indeed, supplements of 100-200 IU/day were successful in raising plasma a-tocopherol to concentrations indistinguishable from those found in controls. Furthermore, by measuring tissue tocopherol concentrations in supplemented patients, it was shown for the first time that these levels can also be raised to normal in CF patients.
Regarding the effects of vitamin E deficiency, this investigation focused on possible hematologic abnormalities. Previous studies have identified abnormal erythrocyte hemolysis in vitro in many, but not all, of the CF patients examined with low plasma tocopherol concentrations (1, 22) . In addition, earlier reports have noted that peroxide hemolysis test results are difficult to reproduce and that samples from healthy subjects with normal tocopherol levels may show as much as 10-20% hemolysis (1, 14, 22) . Because of the difficulties encountered with other hemolysis test procedures, we devoted considerable effort in this study to establishing conditions in which: (a) reproducible results could be obtained with tocopherol-deficient erythrocytes, and (b) control preparations would not hemolyze. With the modifications described in the present report, such a test was developed and found to be useful for our purposes. In particular, it was possible in this study to determine the precise relationship between percentage hemolysis and the plasma a-tocopherol concentration, a relationship which could not be established, beyond the finding of an inverse correlation, in earlier examinations of human erythrocytes (conducted primarily with blood from premature infants) (28). Our results indicate that when the data are plotted in a rectilinear fashion (Fig. 3) , the hemolysis-tocopherol curve is best approximated by a sigmoidal function. Such a relationship was observed previously with rat erythrocytes (19, 29) and suggests that a threshold concentration of vitamin E exists in the erythrocyte below which antioxidant protective activity is virtually exhausted.
There has been considerable disagreement on the question of whether or not significant shortening of the erythrocyte life-span occurs in human tocopherol deficiency (1, (30) (31) (32) . The relatively large population of clinically stable CF patients followed at the National Institutes of Health afforded us an opportunity to examine the issue of in vivo hemolysis in greater detail than was possible previously. Erythrocyte survival determinations in vitamin E-deficient subjects revealed that their erythrocytes were abnormal with a mean ti value of 22.4 days. It should be recognized that this degree of decreased erythrocyte life-span, although statistically significant, is not sufficient to produce frank hemolytic anemia, where values of [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] days are frequently observed. This was substantiated by careful examination of hematologic indices which failed to disclose unexplained anemia in any of our 52 CF patients with vitamin E deficiency. Of greatest interest was the finding that repeat 5'Cr-RBC survival measurements after supplementation with a-tocopherol disclosed a significant increase in ti from 19.0 days to 27.5 days after treatment. This observation provides good evidence that patients with steatorrhea and tocopherol deficiency require vitamin E for maintenance of normal erythrocyte function.
Viewed collectively, observations from our study and from others dealing with vitamin E-deficient patients support the following conclusions: (a) CF patients with complete pancreatic insufficiency are uniformly, and in most cases profoundly, deficient in plasma a-tocopherol. (b) The degree of vitamin E deficiency in patients with long-term steatorrhea occurs to an extent determined by the severity of malabsorption. (c) CF in the absence of significant pancreatic involvement is not accompanied by vitamin E deficiency. (d) Erythrocytes from CF patients with pancreatic achylia are low in a-tocopherol, but the reduction does not occur to as great an extent as in plasma. Thus, the RBC:plasma tocopherol ratio is higher in deficient CF patients compared to controls. (e) Supplements of water-miscible a-tocopheryl acetate will overcome vitamin E deficiency in CF patients and produce normal tocopherol concentrations in both plasma and tissues. (f) With improvements in the peroxide hemolysis test procedure, a sigmoidal relationship between susceptibility of human erythrocytes to H202 and the concentration of tocopherol in plasma was demonstrated for the first time. All CF patients with low blood tocopherol levels show an abnormal degree of hemolysis in vitro when erythrocytes are exposed to oxidant stress. (g) In vivo, however, 51Cr-RBC survival is only mildly to moderately shortened in vitamin E-deficient patients, and not to a degree where hemolytic anemia would occur. The effect of vitamin E deficiency on the hematologic system is, therefore, a subclinical one. Nevertheless, the demonstration of a statistically significant decrease in 5'Cr-RBC half-life, and especially the finding that erythrocyte survival can be corrected upon tocopherol therapy, provides strong evidence that such patients, hence humans in general, require vitamin E for maintenance of normal erythrocyte function. The 
